Evidence map›Paper›PMID 42361778›Full record

ArticleComparative immunology, microbiology and infectious diseases2026

Comparison of Igκ and Igλ binding toward influenza virus hemagglutinin and SARS-CoV-2 Spike protein during primary viral infections in humans, mice, and pigs.

Robert A Richardson, J Fletcher North, Matthew H Thomas, Amanda Lynch, Constantinos S Kyriakis, Giuseppe A Sautto, Ted M Ross

Abstract readComparative Study
In one paragraph

Article in Comparative immunology, microbiology and infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robert A RichardsonFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL, USA; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.
J Fletcher NorthDepartment of Pathobiology, Auburn University, Auburn, AL, USA.
Matthew H ThomasFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL, USA.
Amanda LynchFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL, USA.
Constantinos S KyriakisDepartment of Pathobiology, Auburn University, Auburn, AL, USA.
Giuseppe A SauttoFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL, USA.
Ted M RossFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL, USA; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA, USA. Electronic address: rosst7@ccf.org.

Funding

COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
NIH HHS 75N93019C00052
6 · The paper itself

Abstract

An Igλ light chain bias (IgL) has been identified in ferrets after a primary influenza virus infections. To further study if this phenotype is consistent between species, serum immunoglobulin Igλ and Igκ light chain (IgL) prevalence was evaluated in humans, mice, and pigs following a primary respiratory virus infection. Each IgL population was tested for its binding capacity to the immunodominant viral glycoprotein of the infecting virus. Humans infected with their initial SARS-CoV-2 virus infection had a marginal Igκ bias against the spike (S) glycoprotein, but had no observable IgL bias toward the receptor binding domain of the S protein. Mice had an Igκ bias against the influenza virus hemagglutinin (HA) after a primary infection with an H1N1 or H3N2 influenza virus. Conversely, pigs had an Igλ bias to the HA after a primary infection with either influenza virus subtype. These results highlight that IgL biases vary in different species after a primary viral respiratory infection. Overall, these results have implications for how immunological data should be interpreted between species and the selection of animal models for various applications.

Indexed as

Coronavirus InfectionsHemagglutinin Glycoproteins, Influenza VirusImmunoglobulin lambda-ChainsInfluenza, HumanOrthomyxoviridae InfectionsSARS-CoV-2Spike Glycoprotein, CoronavirusAnimalsAntibodies, ViralFemaleHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeMiceSwineAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusImmunoglobulin lambda-ChainsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antibody light chainHumansLight chain biasMicePigsPrimary infection

Identifiers

PMID42361778
PMCPMC13688495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.